Xieping Dong

Dr. Xieping Dong

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2026 in Materials Today Bio
Verified
Journal Article
Open access
NLNanning Lv
Nanning Lv
HSHaifu Sun
Haifu Sun
XCXiaofan Chen
Xiaofan Chen
HDHe Dong
He Dong
WTWenxiang Tang
Wenxiang Tang
MLMing ming Liu
Ming ming Liu
Diabetic bone defects (DBD) are refractory to repair because chronic inflammation, excessive reactive oxygen species (ROS), and insufficient microangiogenesis disrupt immune, vascular, and osteogenic coupling. Here, we report a smart immune polysaccharide hydrogel (HCSO@ZL) that restores this axis through controlled Zn2+ release and microenvironmental regulation. The hydrogel is formed by coupling L-histidine-modified chitosan with oxidized konjac glucomannan to generate a pH-responsive, self-healing scaffold. Histidine-Zn2+ coordination enables sustained Zn2+ release for 21 days while preventing toxic burst release and, together with the nanoclay network, enhances mechanical performance, with a compressive stress of 150 kPa at 50% strain, 2.5-fold higher than HCSO. In vitro, HCSO@ZL markedly reprogrammed macrophages toward an M2 phenotype, reducing CD86 intensity by 70% relative to HCSO and promoting a metabolic shift from glycolysis to oxidative phosphorylation, accompanied by reduced lactate and succinate levels and increased arginase activity. This immunoregulatory effect translated into enhanced angiogenesis, with 3-fold greater HUVEC migration and 6-fold higher CD31 intensity than HCSO. HCSO@ZL also substantially reduced intracellular ROS and enhanced osteogenic differentiation. Mechanistically, RNA sequencing and molecular validation revealed that HCSO@ZL activates coordinated antioxidant programs through the cAMP/PKA, PI3K/AKT/NRF2, and AKT/FOXO3a axes, promoting nuclear translocation of NRF2, and FOXO3a and broad antioxidant enzyme upregulation. In a diabetic rat femoral defect model, HCSO@ZL achieved near-complete defect repair within 8 weeks, with Tb.Th and BV/TV increased by 1.86-fold and 2.73-fold, respectively, relative to the untreated defect group. This Zn2+-gated immunomodulatory hydrogel provides a safe and effective strategy for diabetic bone regeneration.

1 January 2026 in Oncology Research
Verified
Journal Article
Open access
PDF file
SSShenghui Su
Shenghui Su
YZYu Zeng
Yu Zeng
JCJiaxin Chen
Jiaxin Chen
XDXieping Dong
Xieping Dong
Background: Recent studies have shown glycerolipid metabolism played an essential role in multiple tumors, however, its function in osteosarcoma is unclear. This study aimed to explore the role of glycerolipid metabolism in osteosarcoma. Methods: We conducted bioinformatics analysis using data from the Therapeutically Applicable Research to Generate Effective Treatments (TARGET) database and single-cell RNA sequencing. Least Absolute Shrinkage and Selection Operator (LASSO) regression was used to identify the Glycerolipid metabolism-related genes associated with the clinical outcome of osteosarcoma. Tumor-associated macrophages (TAMs) and their interactions with immune cells were examined through single-cell analysis and co-culture experiments. Virtual screening was employed to identify the potential lysophosphatidic acid receptor 6 (LPAR6) inhibitors. Results: Glycerolipid metabolism-related genes 1-acylglycerol-3-phosphate O-acyltransferase 3 (AGPAT3) and aldehyde dehydrogenase 7 family member A1 (ALDH7A1) were identified as key prognostic genes in osteosarcoma, with high AGPAT3 expression correlating with improved survival. Single-cell analysis revealed that AGPAT3 expression is associated with tumor immune microenvironment, particularly with TAMs. Knockdown of AGPAT3 in osteosarcoma cells resulted in elevated lysophosphatidic acid (LPA) levels, which regulated the immune environment, inhibiting cytotoxic T cell function through TAMs’ LPAR6 signaling. LPAR6 signaling in TAMs mediates immune regulation through cytokine secretion, including interleukin-6 (IL-6) and interleukin-10 (IL-10). Further drug virtual screening identified Dutasteride as a potential inhibitor of LPAR6. Conclusion: AGPAT3 is an important gene related to the prognosis of osteosarcoma. Its ability to modulate LPA signaling and TAM activity offers promising therapeutic opportunities for improving osteosarcoma treatment, particularly in immunotherapy contexts.

8 July 2026 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
YJYifeng Jiang
Yifeng Jiang
XWXingyu Wang
Xingyu Wang
YHYuanqi Hong
Yuanqi Hong
HCHaocong Chen
Haocong Chen
ZWZhe Wang
Zhe Wang
XDXieping Dong
Xieping Dong
Stress shielding-related complications remain a key clinical challenge in total hip arthroplasty (THA). While short-stem prostheses have shown potential bo

6 February 2026 in Medicine
Verified
Journal Article
Open access
SCShuai Chen
Shuai Chen
YGYudong Gan
Yudong Gan
YJYan Jin
Yan Jin
XDXieping Dong
Xieping Dong
FWFeng Wang
Feng Wang
ZZZhongzi Zhang
Zhongzi Zhang
PsA is a chronic inflammatory joint condition associated with psoriasis, and its underlying mechanisms are not fully elucidated. Serum metabolites, as direct reflections of metabolic status, may influence disease progression by regulating immune cell function; however, the causal relationships and specific pathways require further investigation. The present investigation utilized a 2-sample bidirectional MR methodology, leveraging extensive pooled GWAS data to thoroughly evaluate the causal relationships between 1440 serum metabolites and PsA. Additionally, mediation MR analysis was performed to explore the possible mediating effects of 731 immune cell characteristics. In the primary analysis, inverse-variance weighted was employed, and this was further supported by various sensitivity analyses to confirm the reliability of the findings. The genetic method to infer causality analysis revealed significant positive causal associations between 10 serum metabolites and PsA risk, with quinolinate levels demonstrating the most significant correlation (OR = 1.56, 95% CI: 1.26–1.93); while 4 metabolites (e.g., citrate levels, OR = 0.74, 95% CI: 0.61–0.89) exhibited protective effects. Regarding immune cells, 6 cellular features (e.g., CD20 on B cells) were positively correlated with disease risk, whereas 5 features (primarily HLA-DR expression on monocyte subsets) showed negative correlations. Mediation analysis identified 3 significant pathways,the percentage of the effect explained by the mediator: N6,N6,N6-trimethyllysine levels mediated via B cells (CD20 on IgD+ CD38br), with a proportion of 33.2%; 1-stearoyl-2-docosahexaenoyl-GPE (18:0/22:6) levels mediated through monocytes (HLA-DR on CD14− CD16−) with a 32.0% proportion; the unknown metabolite X-24736 also mediated 42.1% of the protective effect via the same monocyte phenotype. This study revealed that elevated amino acid-related metabolites and glycerophospholipids significantly increase PsA risk through immune cell effects. These are closely associated with PsA pathogenesis and may serve as potential biomarkers. The novel findings underscore metabolic-immune interactions as targets for biomarkers and therapies in PsA, advancing personalized medicine.